Geode Capital Management
RMTI icon

Geode Capital Management’s Rockwell Medical RMTI Stock Holding History

Quarter Market Value Status Shares Shares
Change %
Trade Value Portfolio Weight Portfolio Position
2025
Q2
$272K Sell
320,665
-3,874
-1% -$3.29K ﹤0.01% 3771
2025
Q1
$367K Buy
324,539
+4,123
+1% +$4.66K ﹤0.01% 3655
2024
Q4
$654K Buy
320,416
+13,122
+4% +$26.8K ﹤0.01% 3520
2024
Q3
$1.22M Buy
307,294
+1,945
+0.6% +$7.72K ﹤0.01% 3290
2024
Q2
$538K Buy
305,349
+16,589
+6% +$29.2K ﹤0.01% 3545
2024
Q1
$479K Buy
288,760
+4,837
+2% +$8.03K ﹤0.01% 3634
2023
Q4
$537K Buy
283,923
+40,915
+17% +$77.3K ﹤0.01% 3589
2023
Q3
$506K Buy
243,008
+137,036
+129% +$285K ﹤0.01% 3597
2023
Q2
$579K Buy
105,972
+44,461
+72% +$243K ﹤0.01% 3585
2023
Q1
$111K Hold
61,511
﹤0.01% 4301
2022
Q4
$62K Sell
61,511
-161
-0.3% -$162 ﹤0.01% 4535
2022
Q3
$81K Hold
61,672
﹤0.01% 4645
2022
Q2
$79K Sell
61,672
-616,768
-91% -$790K ﹤0.01% 4662
2022
Q1
$319K Hold
678,440
﹤0.01% 4155
2021
Q4
$278K Sell
678,440
-32,840
-5% -$13.5K ﹤0.01% 4331
2021
Q3
$423K Sell
711,280
-93
-0% -$55 ﹤0.01% 4109
2021
Q2
$647K Sell
711,373
-533,117
-43% -$485K ﹤0.01% 3815
2021
Q1
$1.44M Buy
1,244,490
+355,519
+40% +$412K ﹤0.01% 3413
2020
Q4
$897K Sell
888,971
-40,275
-4% -$40.6K ﹤0.01% 3396
2020
Q3
$994K Buy
929,246
+32,066
+4% +$34.3K ﹤0.01% 3211
2020
Q2
$1.75M Buy
897,180
+7,163
+0.8% +$14K ﹤0.01% 2915
2020
Q1
$1.82M Buy
890,017
+89,017
+11% +$182K ﹤0.01% 2716
2019
Q4
$1.95M Buy
801,000
+65,297
+9% +$159K ﹤0.01% 3017
2019
Q3
$2.03M Buy
735,703
+35,372
+5% +$97.6K ﹤0.01% 2935
2019
Q2
$2.11M Buy
700,331
+72,821
+12% +$219K ﹤0.01% 2913
2019
Q1
$3.57M Buy
627,510
+87,723
+16% +$499K ﹤0.01% 2515
2018
Q4
$1.22M Buy
539,787
+57,340
+12% +$129K ﹤0.01% 3021
2018
Q3
$2.04M Buy
482,447
+17,157
+4% +$72.4K ﹤0.01% 2868
2018
Q2
$2.29M Buy
465,290
+46,595
+11% +$230K ﹤0.01% 2773
2018
Q1
$2.18M Buy
418,695
+5,098
+1% +$26.6K ﹤0.01% 2709
2017
Q4
$2.41M Buy
413,597
+5,509
+1% +$32.1K ﹤0.01% 2642
2017
Q3
$3.49M Buy
408,088
+7,557
+2% +$64.7K ﹤0.01% 2416
2017
Q2
$3.18M Buy
400,531
+28,831
+8% +$229K ﹤0.01% 2454
2017
Q1
$2.33M Buy
371,700
+32,964
+10% +$206K ﹤0.01% 2580
2016
Q4
$2.22M Buy
338,736
+8,292
+3% +$54.3K ﹤0.01% 2572
2016
Q3
$2.21M Buy
330,444
+6,720
+2% +$45K ﹤0.01% 2501
2016
Q2
$2.45M Buy
323,724
+16,284
+5% +$123K ﹤0.01% 2355
2016
Q1
$2.31K Buy
307,440
+2,500
+0.8% +$19 ﹤0.01% 2361
2015
Q4
$3.12M Buy
304,940
+5,306
+2% +$54.3K ﹤0.01% 2189
2015
Q3
$2.31M Buy
299,634
+15,517
+5% +$120K ﹤0.01% 2353
2015
Q2
$4.58M Buy
284,117
+14,839
+6% +$239K ﹤0.01% 1949
2015
Q1
$2.94M Buy
269,278
+15,255
+6% +$167K ﹤0.01% 2188
2014
Q4
$2.61M Buy
254,023
+53,420
+27% +$549K ﹤0.01% 2257
2014
Q3
$1.83M Buy
200,603
+11,249
+6% +$103K ﹤0.01% 2409
2014
Q2
$2.27M Buy
189,354
+2,706
+1% +$32.4K ﹤0.01% 2293
2014
Q1
$2.36M Buy
186,648
+5,616
+3% +$71.1K ﹤0.01% 2236
2013
Q4
$1.89M Buy
181,032
+23,113
+15% +$241K ﹤0.01% 2324
2013
Q3
$1.8M Buy
157,919
+13,079
+9% +$149K ﹤0.01% 2236
2013
Q2
$523K Buy
+144,840
New +$523K ﹤0.01% 2847